Product NDC: | 68682-356 |
Proprietary Name: | Flucytosine |
Non Proprietary Name: | Flucytosine |
Active Ingredient(s): | 500 mg/1 & nbsp; Flucytosine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68682-356 |
Labeler Name: | Oceanside Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017001 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20120117 |
Package NDC: | 68682-356-10 |
Package Description: | 100 CAPSULE in 1 BOTTLE (68682-356-10) |
NDC Code | 68682-356-10 |
Proprietary Name | Flucytosine |
Package Description | 100 CAPSULE in 1 BOTTLE (68682-356-10) |
Product NDC | 68682-356 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Flucytosine |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120117 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Oceanside Pharmaceuticals |
Substance Name | FLUCYTOSINE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antifungal [EPC] |